US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816

Oliver W. Press, Hongli Li, Heiko Schöder, David J. Straus, Craig H. Moskowitz, Michael LeBlanc, Lisa M. Rimsza, Nancy L. Bartlett, Andrew M. Evens, Erik S. Mittra, Ann S. LaCasce, John W. Sweetenham, Paul M. Barr, Michelle A. Fanale, Michael V. Knopp, Ariela Noy, Eric D. Hsi, James R. Cook, Mary Jo Lechowicz, Randy D. GascoyneJohn P. Leonard, Brad S. Kahl, Bruce D. Cheson, Richard I. Fisher, Jonathan W. Friedberg

Research output: Contribution to journalArticlepeer-review

162 Scopus citations

Fingerprint

Dive into the research topics of 'US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816'. Together they form a unique fingerprint.

Medicine & Life Sciences